Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma
JS O'Donnell, SK Hunt, KJ Chappell - The Lancet Haematology, 2023 - thelancet.com
The human T-lymphotropic virus type 1 (HTLV-1) retrovirus infects 10–20 million people
globally, with endemic regions in southwestern Japan, the Caribbean basin, Africa, and …
globally, with endemic regions in southwestern Japan, the Caribbean basin, Africa, and …
How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?
CRM Bangham, L Ratner - Current opinion in virology, 2015 - Elsevier
Highlights•Molecular mechanisms of HTLV-1 oncogenesis.•Innate and acquired immune
response to HTLV-1.•Clonality of HTLV-1 in vivo.•We bring together the host and viral factors …
response to HTLV-1.•Clonality of HTLV-1 in vivo.•We bring together the host and viral factors …
Human T-lymphotropic virus type 1 infection
K Tsukasaki, P Koeffler, M Tomonaga - Best Practice & Research Clinical …, 2000 - Elsevier
Human T-cell lymphotropic virus type-1 (HTLV-1) is aetiologically associated with adult T-
cell leukaemia/lymphoma (ATL). HTLV-1 infection can also lead to various non-malignant …
cell leukaemia/lymphoma (ATL). HTLV-1 infection can also lead to various non-malignant …
Human T-lymphotropic virus 1: recent knowledge about an ancient infection
K Verdonck, E González, S Van Dooren… - The Lancet infectious …, 2007 - thelancet.com
Human T-lymphotropic virus 1 (HTLV-1) has infected human beings for thousands of years,
but knowledge about the infection and its pathogenesis is only recently emerging. The virus …
but knowledge about the infection and its pathogenesis is only recently emerging. The virus …
Adult T-cell leukemia/lymphoma and HTLV-1
R Mahieux, A Gessain - Current hematologic malignancy reports, 2007 - Springer
Human T-cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic human
retrovirus to be discovered, more than 25 years ago. HTLV-1 infects 15 to 20 million …
retrovirus to be discovered, more than 25 years ago. HTLV-1 infects 15 to 20 million …
[图书][B] Prevention of human T-cell lymphotropic virus type 1 infection and adult T-cell leukemia/lymphoma
M Yoshimitsu, Y White, N Arima - 2014 - Springer
Adult T-cell leukemia/lymphoma (ATLL) is a highly aggressive peripheral T-cell malignancy
that develops after long-term chronic infection with human T-cell lymphotropic virus type-1 …
that develops after long-term chronic infection with human T-cell lymphotropic virus type-1 …
[引用][C] Australia tackles HTLV-1
K Gruber - The Lancet Infectious Diseases, 2018 - thelancet.com
Human T-cell leukaemia virus type 1 (HTLV-1) is an oncogenic retrovirus that affects as
many as 20 million people worldwide. The virus is of zoonotic origin, and it is commonly …
many as 20 million people worldwide. The virus is of zoonotic origin, and it is commonly …
Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review
A Letafati, R Soheili, M Norouzi, P Soleimani… - Medical Oncology, 2023 - Springer
Adult T-cell leukemia/lymphoma (ATLL), an infrequent malignancy resultant from human T-
cell lymphotropic virus type I (HTLV-1), exhibits a spectrum of phenotypes, encompassing …
cell lymphotropic virus type I (HTLV-1), exhibits a spectrum of phenotypes, encompassing …
Comparative virology of HTLV-1 and HTLV-2
MP Martinez, J Al-Saleem, PL Green - Retrovirology, 2019 - Springer
Human T cell leukemia virus type 1 (HTLV-1) was the first discovered human retrovirus and
the etiologic agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical …
the etiologic agent of adult T-cell leukemia and HTLV-1-associated myelopathy/tropical …
Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions
C de Mendoza, A Rando, E Miró, MJ Pena… - Journal of Clinical …, 2023 - Elsevier
Background HTLV-1 infection is a neglected disease, despite producing neurological and
lymphoproliferative severe illnesses and affect over 10 million people worldwide. Roughly …
lymphoproliferative severe illnesses and affect over 10 million people worldwide. Roughly …